The relationship between hyaluronidase activity and hyaluronic acid concentration in sera from normal controls and from patients with disseminated neoplasm

Clinica Chimica Acta

Volumn 256, Issue 2, 1996, Pages 165-173

  Wilkinson, Christine R ^a   Bower, Lynne M ^a   Warren, Christine ^a  

^a TORBAY HOSPITAL   (United Kingdom)

Author keywords

Disseminated neoplasm; Hyaluronic acid concentrations; Hyaluronidase activity

Indexed keywords

HYALURONIC ACID; HYALURONIDASE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; MALE; MIDDLE AGED; NEOPLASMS; SEX FACTORS;

EID: 0030607718     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(96)06421-2     Document Type: Article

References (27)

1. [1] Cooper EH, Forbes MA. Serum hyaluronic acid levels in cancer. Br J Cancer 1988;58:668-669.
2. [2] Muir H. Proteoglycans of cartilage. J Clin Pathol 1978;31 suppl 12:67-81.
3. [3] Warren C, Manley G. Measurement of serum glycosaminoglycans by laser nephelometry. Clin Chim Acta 1981;116:369-380.
4. [4] Laurent UBG, Tengblad A. Determination of hyaluronate in biological samples by a specific radioassay technique. Anal Biochem 1980;109:386-394.
5. [5] Tengblad A, Laurent UBG, Lilja K et al. Concentration and relative molecular mass of hyaluronate in lymph and blood. Biochem J 1986;236:521-525.
6. [6] Laurent TC, Dahl IMS, Dahl LB et al. The catabolic fate of hyaluronic acid. Connect Tissue Res 1986;15:33-41.
7. [7] Frebourg T, Lerebours G, Delpech B et al. Serum hyaluronate in malignant pleural mesothelioma. Cancer 1987;59:2104-2107.
8. [8] Roden L, Campbell P, Fraser JRE, Laurent TC, Pertoft H, Thompson JN. Enzymic pathways of hyaluronan catabolism. In: The biology of hyaluronan, Chichester: Wiley. Ciba Foundation Symposium 143, 1989;60-86.
9. [9] Chen SS, Hsu DS, Hoffman P. A new micro-assay for hyaluronidase activity. Clin Chim Acta 1979;95:277-284.
10. [10] Bonner WM, Cantey EY. Colorimetric method for the determination of serum hyaluronidase activity. Clin Chim Acta 1966;13:746-752.
11. [11] Cobbin LB, Dicker SE. Some characteristics of plasma and urine 'hyaluronidase'. J Physiol 1962;163:168-174.
12. [12] Fiszer-Szafarz B. Demonstration of new hyaluronidase inhibitor in serum of cancer patients. Proc Soc Exp Biol Med 1968;129:300-302.
13. [13] Wilkinson CR, Bower LM, Warren C. Measurement of hyaluronidase activity in normal human serum. J Pharm Biomed Anal 1996;14:707-712.
14. [14] Herp A, DeFilippi J, Fabianek J. The effect of serum hyaluronidase on acidic polysaccharides and its activity in cancer. Biochim Biophys Acta 1968;158:150-153.
15. [15] Kolarova M, Tobiska J, Brada Z. Host-tumour relationship XXIX. Hyaluronidase activity and seromucoid concentration in blood serum of patients with cancer. Neoplasma 1970;17:641-648.
16. [16] Northup SN, Stasiw RO, Brown HD. Development of the hyaluronidase activity assay as a cancer screening test. Clin Biochem 1973;6:220-228.
17. [17] Swinscow TDV. Statistics at square one. London: British Medical Association, 1983.
18. [18] Siegel S. Nonparametric statistics for the behavioural sciences. International Student Edition. Tokyo, Japan: McGraw-Hill Kogakusha, 1956.
19. [19] Engstrom-Laurent A, Laurent UBG, Lilja K, Laurent TC. Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest 1985;45:497-504.
20. [20] Manley G, Warren C. Serum hyaluronic acid in patients with disseminated neoplasm. J Clin Pathol 1987;40:626-630.
21. [21] Kumar S, West DC, Ponting JM, Gattamaneni HR. Sera of children with renal tumours contain low-molecular mass hyaluronic acid. Int J Cancer 1989;44:445-448.
22. [22] Makito A, Shimojo H. Polysaccharides of SV40-transformed green monkey kidney cells. Biochim Biophys Acta 1973;304:571-574.
23. [23] Knudson W, Biswas C, Toole BP, Interactions between human tumour cells and fibroblasts stimulates hyaluronate synthesis. Proc Natl Acad Sci USA 1984;81:6767-6771.
24. [24] Turley EA, Austen L, Vandeligt K, Clary C. Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J Cell Biol 1991;112:1041-1047.
25. [25] Fiszer-Szafarz B, Gullino PM. Hyaluronic acid content of the interstitial fluid of Walker carcinoma 256. Proc Soc Exp Biol Med 1970;133:597-600.
26. [26] Fiszer-Szafarz B, Gullino PM. Hyaluronidase activity of normal and neoplastic interstitial fluid. Proc Soc Exp Biol Med 1970;133:805-807.
27. [27] West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985;228:1324-1326.